Research facility · founded 1892

The Wistar Institute

Philadelphia, United States · wistar.org

Manage this page

Citations, last 5 years: 13.8k
Works, last 5 years: 2 014
h-index: 580
Scientists listed: 246
Grants since 2016: 630

Grants received

2016–2019 · grant · OCRP

Synthetic Lethal Therapeutic Approaches for ARID1A-Mutated Ovarian Cancer

Rugang Zhang · The Wistar Institute · funded by Congressionally Directed Medical Research Programs

$818.6k

2016–2022 · research · R01

Targeting telomerase for melanoma therapeutics

Emmanuel Skordalakes · The Wistar Institute · funded by National Institutes of Health

$471.4kTelomeres, Telomerase, and Senescence

2016–2026 · research · R50

Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level

Andrew V Kossenkov · The Wistar Institute · funded by National Institutes of Health

$150.3k

2015–2026 · research · R01

Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer

Rugang Zhang · The Wistar Institute · funded by National Institutes of Health

$434.7kChromatin Remodeling and Cancer

2015–2020 · research · R01

p53 Variants in Cancer Risk and Therapy

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$466.4kCancer-related Molecular Pathways

2015–2020 · cooperative agreement · U19

Synthetic DNA & Novel Env Vaccine for HIV

David B. Weiner · The Wistar Institute · funded by National Institutes of Health

$3.3M

2015–2020 · research · R01

Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer

Rugang Zhang · The Wistar Institute · funded by National Institutes of Health

$434.6kChromatin Remodeling and Cancer

2015–2020 · research · R01

Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer

Rugang Zhang · The Wistar Institute · funded by National Institutes of Health

$434.6kChromatin Remodeling and Cancer

2015–2020 · research · R01

Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer

Rugang Zhang · The Wistar Institute · funded by National Institutes of Health

$434.6kChromatin Remodeling and Cancer

2015–2021 · research · R01

Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer

Rugang Zhang · The Wistar Institute · funded by National Institutes of Health

$434.6kChromatin Remodeling and Cancer

2015–2023 · research · R01

Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer

Rugang Zhang · The Wistar Institute · funded by National Institutes of Health

$119.2kChromatin Remodeling and Cancer

2015–2020 · research · R01

p53 Variants in Cancer Risk and Therapy

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$421.4kCancer-related Molecular Pathways

2015–2021 · research · R01

p53 Variants in Cancer Risk and Therapy

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$429.5kCancer-related Molecular Pathways

2015–2020 · research · R01

p53 Variants in Cancer Risk and Therapy

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$416kCancer-related Molecular Pathways

2015–2020 · research · R01

p53 Variants in Cancer Risk and Therapy

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$428.3kCancer-related Molecular Pathways

2015–2020 · cooperative agreement · U19

Synthetic DNA & Novel Env Vaccine for HIV

David B. Weiner · The Wistar Institute · funded by National Institutes of Health

$3.4M

2015–2020 · research · R01

Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer

Rugang Zhang · The Wistar Institute · funded by National Institutes of Health

$421.6kChromatin Remodeling and Cancer

2015–2023 · cooperative agreement · U19

Synthetic DNA & Novel Env Vaccine for HIV

David B. Weiner · The Wistar Institute · funded by National Institutes of Health

$3.4M

2015–2020 · cooperative agreement · U19

Synthetic DNA & Novel Env Vaccine for HIV

David B. Weiner · The Wistar Institute · funded by National Institutes of Health

$3.3M

2014–2020 · research · R01

Promotion of tumor invasion and pseudosenescence by the aging microenvironment

Ashani T Weeraratna · The Wistar Institute · funded by National Institutes of Health

$59.3k

2014–2020 · research · R01

Promotion of tumor invasion and pseudosenescence by the aging microenvironment

Ashani T Weeraratna · The Wistar Institute · funded by National Institutes of Health

$394.3k

2014–2020 · research · R01

Development of a Small Molecule Inhibitor for KSHV LANA

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$394.3k

2014–2021 · program · P50

SPORE in Skin Cancer

Meenhard F Herlyn · The Wistar Institute · funded by National Institutes of Health

$2.3M

2013–2024 · research · R01

Targeting ER stress response in B-cell chronic lymphocytic leukemia

Chih-Chi Andrew Hu · The Wistar Institute · funded by National Institutes of Health

$451.4kEndoplasmic Reticulum Stress and Disease

2013–2020 · research · R01

Targeting ER stress response in B-cell chronic lymphocytic leukemia

Chih-Chi Andrew Hu · The Wistar Institute · funded by National Institutes of Health

$427.7kEndoplasmic Reticulum Stress and Disease

2012–2022 · research · R01

Chromatin basis of cellular senescence and its implication in epithelial ovarian cancer

Rugang Zhang · The Wistar Institute · funded by National Institutes of Health

$423.2kTelomeres, Telomerase, and Senescence

2012–2023 · research · R01

Targeting EZH2 in CARM1-expressing epithelial ovarian cancer

Rugang Zhang · The Wistar Institute · funded by National Institutes of Health

$263.8kCancer-related gene regulation

2012–2022 · research · R01

Targeting EZH2 in CARM1-expressing epithelial ovarian cancer

Rugang Zhang · The Wistar Institute · funded by National Institutes of Health

$406.1kCancer-related gene regulation

2012–2023 · research · R01

Chromatin basis of cellular senescence and its implication in epithelial ovarian cancer

Rugang Zhang · The Wistar Institute · funded by National Institutes of Health

$221.3kTelomeres, Telomerase, and Senescence

2012–2022 · research · R01

Targeting EZH2 in CARM1-expressing epithelial ovarian cancer

Rugang Zhang · The Wistar Institute · funded by National Institutes of Health

$406.1kCancer-related gene regulation

2012–2022 · research · R01

Targeting EZH2 in CARM1-expressing epithelial ovarian cancer

Rugang Zhang · The Wistar Institute · funded by National Institutes of Health

$393.9kCancer-related gene regulation

2012–2022 · research · R01

Chromatin basis of cellular senescence and its implication in epithelial ovarian cancer

Rugang Zhang · The Wistar Institute · funded by National Institutes of Health

$423.2kTelomeres, Telomerase, and Senescence

2012–2022 · research · R01

Targeting EZH2 in CARM1-expressing epithelial ovarian cancer

Rugang Zhang · The Wistar Institute · funded by National Institutes of Health

$406.1kCancer-related gene regulation

2012–2023 · research · R01

Lipids and Myeloid Cell Function in Cancer

Dmitry I Gabrilovich · The Wistar Institute · funded by National Institutes of Health

$422.2kImmune cells in cancer

2012–2023 · research · R01

Lipids and Myeloid Cell Function in Cancer

Valerian E Kagan · The Wistar Institute · funded by National Institutes of Health

$402.2kImmune cells in cancer

2012–2022 · research · R01

Chromatin basis of cellular senescence and its implication in epithelial ovarian cancer

Rugang Zhang · The Wistar Institute · funded by National Institutes of Health

$410.5kTelomeres, Telomerase, and Senescence

2012–2023 · research · R01

Lipids and Myeloid Cell Function in Cancer

Valerian E Kagan · The Wistar Institute · funded by National Institutes of Health

$390.2kImmune cells in cancer

2012–2022 · research · R01

Chromatin basis of cellular senescence and its implication in epithelial ovarian cancer

Rugang Zhang · The Wistar Institute · funded by National Institutes of Health

$423.2kTelomeres, Telomerase, and Senescence

2012–2023 · research · R01

Lipids and Myeloid Cell Function in Cancer

Valerian E Kagan · The Wistar Institute · funded by National Institutes of Health

$402.2kImmune cells in cancer

2012–2024 · research · R01

Lipids and Myeloid Cell Function in Cancer

Valerian E Kagan · The Wistar Institute · funded by National Institutes of Health

$394.2kImmune cells in cancer